Technology News and Research

RSS

Amorcyte reports AMR-001 phase I trial results in heart attack patients

The American Heart Journal today reported results of a clinical trial evaluating Amorcyte, lead product candidate, AMR-001 for the treatment of damaged heart muscle following acute myocardial infarction.

22 Dec 2010

Quick-Med, Foster complete joint development program for NIMBUS antimicrobial catheters

Quick-Med Technologies, Inc. announced today that it has successfully completed its joint development program with Foster Corporation, a member of PolyMedex Discovery Group, to collaborate in applying Quick-Med's proprietary NIMBUS® technology to thermoplastics for catheters and other medical product applications.

22 Dec 2010

El Camino announces first patient implant in Medtronic CoreValve clinical trial

El Camino Hospital today announced its first patient implant in the Medtronic CoreValve® U.S. Clinical Trial.

22 Dec 2010

Esprida software solution can help improve patient care

Esprida Corporation, a leading remote device management platform solution provider, today announced its partnership with Careworx Inc., a technology vendor and consulting firm dedicated to working with long-term healthcare facilities.

22 Dec 2010

Popular Science magazine honors ONR-funded researchers on 2010 'Brilliant 10' list

Dubbed the "Brilliant 10" by Popular Science, two researchers on the magazine's recently released 2010 list of top young scientists have received funding from the Office of Naval Research (ONR).

22 Dec 2010

Nature News explores developing countries' commitment to R&D

Nature News explores how a report published last week by the Organisation for Economic Co-operation and Development (OECD) documents the growing commitment of several developing countries to R&D (Casassus, 12/20).

22 Dec 2010

People with type 1 diabetes could grow their own insulin-producing cells, say researchers

At the annual meeting of the American Society for Cell Biology last week in Philadelphia, researchers from Georgetown University Medical Center in Washington, D.C., announced that it may be possible for people with type 1 diabetes to grow their own insulin-producing cells, a breakthrough that could lead to a cure for the disease.

22 Dec 2010

Verizon grants will eanble heart attack patients to receive life-saving treatments more quickly

Heart attack patients can receive life-saving treatments more quickly thanks to $100,000 in grants from the Verizon Foundation to the Foundation of UMDNJ for a program that enables heart attack patients to bypass the emergency room and go directly to the cardiac catheterization laboratory at UMDNJ-The University Hospital.

22 Dec 2010

MiMedx to acquire Surgical Biologics

MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it has signed a definitive agreement to acquire Surgical Biologics, a leader in the development of tissue processing techniques for creating implants for a variety of surgical indications from amnion membranes.

22 Dec 2010

Presence of CTCs may predict disease recurrence in patients with neck and head cancer

A new study suggests that the presence of tumor cells in the circulating blood of patients with squamous cell cancer of the head and neck may predict disease recurrence and reduced survival.

21 Dec 2010

URI, R.I. Hospital to offer medical physics degree

Students interested in physics and medicine will be able to combine disciplines to become medical physicists and enter an expanding field that offers multiple career opportunities and salaries that start with six figures.

21 Dec 2010

CoreMatrix delivers new cloud based, integrated, on demand marketing solutions

CoreMatrix Systems™, one of the country's leading cloud computing consulting and Software-as-a-Service (SaaS) development companies, announced today that it has developed and delivered two new integrated, on demand marketing solutions. Built on Aprimo Marketing Studio® On Demand, the cloud-based solutions are designed to empower marketers to more efficiently execute and measure integrated marketing campaigns, while reducing costs, for improved ROI.

21 Dec 2010

Isis commences ISIS-APOCIIIRx Phase 1 trial in hypertriglyceridemia

Isis Pharmaceuticals, Inc. announced the initiation of a Phase 1 study of ISIS-APOCIIIRx, an antisense drug designed to lower triglycerides to treat a variety of diseases associated with elevated triglycerides. Hypertriglyceridemia, a condition characterized by elevated levels of triglycerides, is an independent risk factor for cardiovascular disease and is a component of numerous cardiovascular and metabolic diseases, including metabolic syndrome.

21 Dec 2010

Biovest issues FAQ update on BiovaxID personalized cancer vaccine

Biovest International, Inc. today issued the following update in the form of a "Frequently Asked Questions" report in response to the high volume of inquiries received following the Company's recent presentation at the 2010 American Society of Hematology Annual Meeting (ASH 2010) in Orlando, Florida.

21 Dec 2010

CIOs need to identify where IT needs to be

"Chief Information Officers (CIOs) need to perform a gap analysis to identify where Information Technology (IT) needs to be, from a business and not an IT perspective," advises Greg Johnson, Chief Technology Officer at the Virginia Commonwealth University Health System. Healthcare organizations must be able to work smart, which means that virtualization, standardization and simplification of the IT environment are necessary for meeting growing organizational goals.

21 Dec 2010

Investigator to receive AGA-General Mills Bell Institute of Health and Nutrition Research Scholar Award

The American Gastroenterological Association Foundation for Digestive Health and Nutrition announced that Anisa Shaker, MD, is the recipient of the AGA-General Mills Bell Institute of Health and Nutrition Research Scholar Award in Gut Physiology and Health.

21 Dec 2010

B-Bridge International unveils first brainwave athletic trainer

B-Bridge International proudly unveils the first brainwave athletic trainer. Powered by NeuroSky, the leader in mass-market Brain-Computer Interface technology, the BrainAthlete system is the first sports training unit available for general consumers to track an athlete's level of concentration, helping them find their "zone." Engineered into a standard golf visor, three non-invasive contact points in the headband monitor the EEG electrical activity from the brain to determine the athlete's mental states.

21 Dec 2010

Aetna's ACO model improves health care quality, lowers cost of care

Three years ago Aetna began working with doctor groups, specialists and health care facilities to create a more personalized, connected and accountable way to provide health care. Today, Aetna's early accountable care organization model is improving health care quality and lowering the cost of care.

21 Dec 2010

Emisphere, Novo Nordisk partner to develop and commercialize oral formulations of insulins

Emisphere Technologies, Inc. and Novo Nordisk A/S today announced that they have entered into an exclusive Development and License Agreement to develop and commercialize oral formulations of Novo Nordisk's insulins, which have the potential of treating diabetes, using Emisphere's Eligen® Technology. This is the second license agreement between the two companies. The first agreement, for the development of oral formulations of GLP-1 receptor agonists, was signed in June 2008, with a potential drug currently in a Phase I clinical trial.

21 Dec 2010

Damon Runyon Cancer Research Foundation names first recipients of Frey Award for Breakthrough Scientists

The Damon Runyon Cancer Research Foundation, a non-profit organization focused on supporting innovative early career researchers, named the first recipients of the Dale F. Frey Award for Breakthrough Scientists. This new award provides additional funding to scientists completing a prestigious Damon Runyon Fellowship Award who have greatly exceeded the Foundation's highest expectations and are most likely to make paradigm-shifting breakthroughs that transform the way we prevent, diagnose and treat cancer.

21 Dec 2010

Technology News and Research

Amorcyte reports AMR-001 phase I trial results in heart attack patients

Quick-Med, Foster complete joint development program for NIMBUS antimicrobial catheters

El Camino announces first patient implant in Medtronic CoreValve clinical trial

Esprida software solution can help improve patient care

Popular Science magazine honors ONR-funded researchers on 2010 'Brilliant 10' list

Nature News explores developing countries' commitment to R&D

People with type 1 diabetes could grow their own insulin-producing cells, say researchers

Verizon grants will eanble heart attack patients to receive life-saving treatments more quickly

MiMedx to acquire Surgical Biologics

Presence of CTCs may predict disease recurrence in patients with neck and head cancer

URI, R.I. Hospital to offer medical physics degree

CoreMatrix delivers new cloud based, integrated, on demand marketing solutions

Isis commences ISIS-APOCIIIRx Phase 1 trial in hypertriglyceridemia

Biovest issues FAQ update on BiovaxID personalized cancer vaccine

CIOs need to identify where IT needs to be

Investigator to receive AGA-General Mills Bell Institute of Health and Nutrition Research Scholar Award

B-Bridge International unveils first brainwave athletic trainer

Aetna's ACO model improves health care quality, lowers cost of care

Emisphere, Novo Nordisk partner to develop and commercialize oral formulations of insulins

Damon Runyon Cancer Research Foundation names first recipients of Frey Award for Breakthrough Scientists

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News